By situating GABRD within the growing field of neurotransmitter‐driven oncogenesis, we provide foundational evidence for further mechanistic investigations, including possible electrophysiological and microenvironmental interventions in gastric cancer. The gene discussed is GABRD; the disease is gastric cancer.